# Michael D. Prados

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/michael-d-prados/

## Facts

| Field | Value |
| --- | --- |
| Citations | 82,208 |
| Field | Glioma Diagnosis and Treatment |
| h-index | 125 |
| i10-index | 379 |
| Last Known Institution | University of California, San Francisco |
| OpenAlex ID | https://openalex.org/A5046264008 |
| ORCID iD | https://orcid.org/0000-0002-9630-2075 |
| Works | 731 |

## Researcher papers

- [Comprehensive genomic characterization defines human glioblastoma genes and core pathways](https://scholariq.org/papers/comprehensive-genomic-characterization-defines-human-glioblastoma-genes-and-core/)
- [The Somatic Genomic Landscape of Glioblastoma](https://scholariq.org/papers/the-somatic-genomic-landscape-of-glioblastoma/)
- [Association of Maximal Extent of Resection of Contrast-Enhanced and Non–Contrast-Enhanced Tumor With Survival Within Molecular Subgroups of Patients With Newly Diagnosed Glioblastoma](https://scholariq.org/papers/association-of-maximal-extent-of-resection-of-contrast-enhanced-and-non-contrast/)
- [Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma](https://scholariq.org/papers/phase-iii-randomized-trial-of-ced-of-il13-pe38qqr-vs-gliadel-wafers-for/)
- [Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma](https://scholariq.org/papers/recurrent-somatic-mutations-in-acvr1-in-pediatric-midline-high-grade-astrocytoma/)
- [Evidence for Sequenced Molecular Evolution of <i>IDH1</i> Mutant Glioblastoma From a Distinct Cell of Origin](https://scholariq.org/papers/evidence-for-sequenced-molecular-evolution-of-i-idh1-i-mutant-glioblastoma-from/)
- [Randomized Study of Two Chemotherapy Regimens for Treatment of Low-Grade Glioma in Young Children: A Report From the Children's Oncology Group](https://scholariq.org/papers/randomized-study-of-two-chemotherapy-regimens-for-treatment-of-low-grade-glioma/)
- [Phase II Study of Erlotinib Plus Temozolomide During and After Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma](https://scholariq.org/papers/phase-ii-study-of-erlotinib-plus-temozolomide-during-and-after-radiation-therapy/)
- [Differential Sensitivity of Glioma- versus Lung Cancer–Specific EGFR Mutations to EGFR Kinase Inhibitors](https://scholariq.org/papers/differential-sensitivity-of-glioma-versus-lung-cancer-specific-egfr-mutations-to/)

## Researcher topics

- [Glioma Diagnosis and Treatment](https://scholariq.org/topics/glioma-diagnosis-and-treatment/)
- [Brain Metastases and Treatment](https://scholariq.org/topics/brain-metastases-and-treatment/)
- [Meningioma and schwannoma management](https://scholariq.org/topics/meningioma-and-schwannoma-management/)
- [Neuroblastoma Research and Treatments](https://scholariq.org/topics/neuroblastoma-research-and-treatments/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)

## Researcher university

- [University of California, San Francisco](https://scholariq.org/institutions/university-of-california-san-francisco/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.